243 related articles for article (PubMed ID: 36685566)
1. Functional status and spatial interaction of T cell subsets driven by specific tumor microenvironment correlate with recurrence of non-small cell lung cancer.
Yang L; Zhang W; Sun J; Yang G; Cai S; Sun F; Xing L; Sun X
Front Immunol; 2022; 13():1022638. PubMed ID: 36685566
[TBL] [Abstract][Full Text] [Related]
2. Functional status and spatial architecture of tumor-infiltrating CD8+ T cells are associated with lymph node metastases in non-small cell lung cancer.
Yang G; Cai S; Hu M; Li C; Yang L; Zhang W; Sun J; Sun F; Xing L; Sun X
J Transl Med; 2023 May; 21(1):320. PubMed ID: 37173705
[TBL] [Abstract][Full Text] [Related]
3. The role of spatial interplay patterns between PD-L1-positive tumor cell and T cell in recurrence of locally advanced non-small cell lung cancer.
Yang L; Zhang W; Sun J; Yang G; Cai S; Sun F; Xing L; Sun X
Cancer Immunol Immunother; 2023 Jul; 72(7):2015-2027. PubMed ID: 36738309
[TBL] [Abstract][Full Text] [Related]
4. Stromal PD-L1-Positive Regulatory T cells and PD-1-Positive CD8-Positive T cells Define the Response of Different Subsets of Non-Small Cell Lung Cancer to PD-1/PD-L1 Blockade Immunotherapy.
Wu SP; Liao RQ; Tu HY; Wang WJ; Dong ZY; Huang SM; Guo WB; Gou LY; Sun HW; Zhang Q; Xie Z; Yan LX; Su J; Yang JJ; Zhong WZ; Zhang XC; Wu YL
J Thorac Oncol; 2018 Apr; 13(4):521-532. PubMed ID: 29269008
[TBL] [Abstract][Full Text] [Related]
5. Spatial Density and Distribution of Tumor-Associated Macrophages Predict Survival in Non-Small Cell Lung Carcinoma.
Zheng X; Weigert A; Reu S; Guenther S; Mansouri S; Bassaly B; Gattenlöhner S; Grimminger F; Pullamsetti S; Seeger W; Winter H; Savai R
Cancer Res; 2020 Oct; 80(20):4414-4425. PubMed ID: 32699134
[TBL] [Abstract][Full Text] [Related]
6. Location of CD39
Koppensteiner L; Mathieson L; Pattle S; Dorward DA; O'Connor R; Akram AR
J Immunother Cancer; 2023 Aug; 11(8):. PubMed ID: 37648263
[TBL] [Abstract][Full Text] [Related]
7. Association of lymphocyte subsets with efficacy and prognosis of immune checkpoint inhibitor therapy in advanced non-small cell lung carcinoma: a retrospective study.
Yan Y; Wang X; Liu C; Jia J
BMC Pulm Med; 2022 Apr; 22(1):166. PubMed ID: 35484541
[TBL] [Abstract][Full Text] [Related]
8. Spatial interaction of tumor cells and regulatory T cells correlates with survival in non-small cell lung cancer.
Barua S; Fang P; Sharma A; Fujimoto J; Wistuba I; Rao AUK; Lin SH
Lung Cancer; 2018 Mar; 117():73-79. PubMed ID: 29409671
[TBL] [Abstract][Full Text] [Related]
9. Spatial immunophenotyping of the tumour microenvironment in non-small cell lung cancer.
Backman M; Strell C; Lindberg A; Mattsson JSM; Elfving H; Brunnström H; O'Reilly A; Bosic M; Gulyas M; Isaksson J; Botling J; Kärre K; Jirström K; Lamberg K; Pontén F; Leandersson K; Mezheyeuski A; Micke P
Eur J Cancer; 2023 May; 185():40-52. PubMed ID: 36963351
[TBL] [Abstract][Full Text] [Related]
10. Spatial features of specific CD103
Yang G; Cai S; Hu M; Li C; Yang L; Zhang W; Sun J; Sun F; Xing L; Sun X
J Transl Med; 2024 Jan; 22(1):27. PubMed ID: 38183111
[TBL] [Abstract][Full Text] [Related]
11. CD8+CD28- cells and CD4+CD25+ regulatory T cells in the peripheral blood of advanced stage lung cancer patients.
Karagöz B; Bilgi O; Gümüs M; Erikçi AA; Sayan O; Türken O; Kandemir EG; Oztürk A; Yaylaci M
Med Oncol; 2010 Mar; 27(1):29-33. PubMed ID: 19148592
[TBL] [Abstract][Full Text] [Related]
12. Multiplex immunofluorescence and single-cell transcriptomic profiling reveal the spatial cell interaction networks in the non-small cell lung cancer microenvironment.
Peng H; Wu X; Liu S; He M; Xie C; Zhong R; Liu J; Tang C; Li C; Xiong S; Zheng H; He J; Lu X; Liang W
Clin Transl Med; 2023 Jan; 13(1):e1155. PubMed ID: 36588094
[TBL] [Abstract][Full Text] [Related]
13. Prognostic effect of epithelial and stromal lymphocyte infiltration in non-small cell lung cancer.
Al-Shibli KI; Donnem T; Al-Saad S; Persson M; Bremnes RM; Busund LT
Clin Cancer Res; 2008 Aug; 14(16):5220-7. PubMed ID: 18698040
[TBL] [Abstract][Full Text] [Related]
14. [Clinical significance of CD4+ CD25+ regulatory T-cells detection in tumor-draining lymph nodes of nonsmall cell lung cancer patients].
Su YJ; Ren K; Li H; Ren XB; Wang CL
Zhonghua Zhong Liu Za Zhi; 2007 Dec; 29(12):922-6. PubMed ID: 18478932
[TBL] [Abstract][Full Text] [Related]
15. Dysfunction of CD8
Li C; Hu M; Cai S; Yang G; Yang L; Jing H; Xing L; Sun X
Cancer Sci; 2024 May; ():. PubMed ID: 38720474
[TBL] [Abstract][Full Text] [Related]
16. APE1 may influence CD4+ naïve T cells on recurrence free survival in early stage NSCLC.
Li Y; Zhao X; Xiao H; Yang B; Liu J; Rao W; Dai X; Li M; Dai N; Yang Y; Wang D
BMC Cancer; 2021 Mar; 21(1):233. PubMed ID: 33676448
[TBL] [Abstract][Full Text] [Related]
17. Prognostic impact of tumor-infiltrating lymphocytes in non-small cell lung carcinomas.
Mlika M; Saidi A; Mejri N; Abdennadher M; Haddouchi C; Labidi S; Khiari H; Boussen H; Hsairi M; Mezni F
Asian Cardiovasc Thorac Ann; 2022 Feb; 30(2):177-184. PubMed ID: 34558296
[TBL] [Abstract][Full Text] [Related]
18.
Yaegashi LB; Baldavira CM; Prieto TG; Machado-Rugolo J; Velosa APP; da Silveira LKR; Assato A; Ab'Saber AM; Falzoni R; Takagaki T; Silva PL; Teodoro WR; Capelozzi VL
Front Immunol; 2021; 12():714230. PubMed ID: 34484217
[TBL] [Abstract][Full Text] [Related]
19. Clinical significance of PD-L1-positive cancer-associated fibroblasts in pN0M0 non-small cell lung cancer.
Teramoto K; Igarashi T; Kataoka Y; Ishida M; Hanaoka J; Sumimoto H; Daigo Y
Lung Cancer; 2019 Nov; 137():56-63. PubMed ID: 31546072
[TBL] [Abstract][Full Text] [Related]
20. Tumor-infiltrating regulatory T cells inhibit endogenous cytotoxic T cell responses to lung adenocarcinoma.
Ganesan AP; Johansson M; Ruffell B; Yagui-Beltrán A; Lau J; Jablons DM; Coussens LM
J Immunol; 2013 Aug; 191(4):2009-17. PubMed ID: 23851682
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]